Expanding the Treatment Options for Women with Gynecologic Cancers
The management of gynecologic cancers is changing dramatically and our team of physicians is at the forefront of adapting treatment options to incorporate the most recent advances.
Surgically, the biggest impact has been the use of laparoscopic robotic surgery for removal of the uterus, fallopian tubes, ovaries and lymph nodes in women with uterine cancer. Uterine cancer is the most common type of gynecological cancer. Most uterine cancer comes from the inner lining of the uterus called the endometrium. Uterine cancer, also known as endometrial cancer, usually occurs around the time of menopause. There is no screening test for it (the PAP test only screens for cervical cancer).
Laparoscopic robotic surgery is also being offered to women with
invasive cervical cancer requiring radical hysterectomy. Women undergoing risk reducing surgery for
BRCA gene mutations or Lynch Syndrome are also candidates. Gynecologic oncology surgeons,
Steve H. Berliner, MD and Michael G.
Kelly, MD perform multiple laparoscopic robotic operations every
week at Wake Forest Baptist Medical Center.
Ovarian cancer is the leading cause of death among gynecologic cancers. Only 15% of ovarian cancers are detected at the earliest, most curable stage. Historically,
all women diagnosed with ovarian cancer underwent surgery to remove as much of the tumor as possible, followed by standard chemotherapy. However, not all ovarian cancers respond well
to this approach. Advances in personalized medicine have shown antiestrogen therapy to be effective in patients with low grade ovarian cancers, while "dose-dense" chemotherapy can improve survival in patients with high-grade ovarian cancer.
We also have expertise in evaluating women at increased risk for developing ovarian cancer. For patients who don't want to undergo complete hysterectomy, we can offer surgical alternatives to preserve the ovaries while lessening the risk of developing ovarian cancer.
If ovarian cancer is suspected or diagnosed, seek care from a gynecologic oncologist. Samuel S. Lentz, MD, director of gynecologic oncology at Wake Forest Baptist, is a nationally recognized expert in the surgical and medical management of women with ovarian cancer.
Our gynecologic oncology team is composed of top-notch physicians, surgeons, nurse practitioners,and nurses which allows us to develop special, long-term relationships with our patients and their families.